Whereas, treatment with MP (10 mg/kg) significantly (p < 0.05) inhibited BLM-induced up-regulated lung collagen-1, TGF-β, and Smad-3 mRNA expressions as compared to BLM controlled rats. The gene discussed is SMAD3; the disease is Bloom syndrome.